Holen Sie sich die Stockscreener-App
233.31
2.17%
4.95
Handel nachbörslich:
233.11
-0.20
-0.09%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$228.36
Offen:
$230.39
24-Stunden-Volumen:
9.05M
Relative Volume:
0.77
Marktkapitalisierung:
$291.35B
Einnahmen:
$20.56B
Nettoeinkommen (Verlust:
$6.21B
KGV:
47.82
EPS:
4.8791
Netto-Cashflow:
$6.22B
1W Leistung:
+6.34%
1M Leistung:
-3.70%
6M Leistung:
+76.84%
1J Leistung:
+207.63%
1-Tages-Spanne:
$227.06
$239.52
1-Wochen-Bereich:
$215.00
$239.52
52-Wochen-Spanne:
$56.32
$256.68
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
233.31 | 285.17B | 20.56B | 6.21B | 6.22B | 4.8791 |
ASML
Asml Holding Nv
|
1,369.62 | 507.69B | 36.97B | 10.86B | 12.49B | 27.95 |
AMAT
Applied Materials Inc
|
361.79 | 283.37B | 28.21B | 7.84B | 6.19B | 9.7629 |
KLAC
Kla Corp
|
1,511.38 | 196.44B | 12.74B | 4.56B | 4.38B | 34.42 |
TER
Teradyne Inc
|
303.92 | 45.53B | 3.19B | 554.05M | 450.41M | 3.483 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2026-01-29 | Bestätigt | TD Cowen | Buy |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Lam Research Corp (LRCX) Trading 3.1% Higher on Mar 23 - GuruFocus
Lam Research Corporation (LRCX) Eyes $135 billion Opportunity - Yahoo Finance
Gradient Investments LLC Lowers Stake in Lam Research Corporation $LRCX - MarketBeat
Is Lam Research Corporation (LRCX) eyeing Besi Industries merger amid IBM pact for logic scaling - MSN
Is Lam Research Corporation (LRCX) Eyeing Besi Industries Merger amid IBM Pact for Logic Scaling - Yahoo Finance UK
Tounjian Advisory Partners LLC Takes $2.20 Million Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation (LRCX) partners with IBM - MSN
Lam Research Corp. Hits Day High with Strong 3.39% Intraday Surge - Markets Mojo
Lam Research Corp (NASDAQ:LRCX) Passes Minervini Trend Template with Strong Growth Momentum - ChartMill
15 Best Forever Stocks to Buy Now - Insider Monkey
Lam Research Corp Stock (LRCX) Moved Down by 3.19% on Mar 20: What Signal Does It Send? - TradingKey
MU vs. LRCX: Which Semiconductor Stock Is the Better Bet Now? - The Globe and Mail
Lam Research Corp. Hits Day High with Strong 3.32% Intraday Surge - Markets Mojo
LRCX Price History for Lam Research Corp Stock - Barchart
What if ASML Becomes the Next Trillion-Dollar Stock? - The Motley Fool
Lam Research Corp. stock outperforms competitors on strong trading day - MSN
Lam Research Corp. stock underperforms Friday when compared to competitors - MSN
Lam Research Corp Stock (LRCX) Opened Down by 3.41% on Mar 19: Key Drivers Unveiled - TradingKey
Can Lam Research's Systems Business Sustain Growth Amid AI Capex Boom? - Yahoo! Finance Canada
IBM And Lam Research Corporation Partner To Drive Sub-1nm Logic Scaling Advances - Electronics For You BUSINESS
Lam Research Corp. (LRCX) targets growth in foundry and logic markets - MSN
IBM and Lam Research Collaborating to Advance Sub-1nm Logic Scaling - EE Times India
Lam Research Corp. Experiences Valuation Adjustment Amid Strong Financial Performance Metrics - Markets Mojo
Lam Research Corp. stock outperforms competitors despite losses on the day - MSN
Lam Research Corp. Hits Day Low at $230.78 Amid Price Pressure - Markets Mojo
Lam Research Corp. Hits Day High with Strong 3.22% Intraday Surge - Markets Mojo
Lam Research Stock Performance & Financial Analysis 2026News and Statistics - IndexBox
Lam Research Corporation $LRCX Shares Acquired by WBI Investments LLC - MarketBeat
Lam is only wafer fab equipment firm on 2026 ethics list - Stock Titan
Lam Research Corporation $LRCX Shares Bought by Advisory Services Network LLC - MarketBeat
LRCX Stock Price, Quote & Chart | LAM RESEARCH CORP (NASDAQ:LRCX) - ChartMill
3 Reasons We Love Lam Research (LRCX) - Barchart.com
Lam Research Corporation (LRCX) Collaborates With JSR Corporation - MSN
Lam Research Corp Stock (LRCX) Closed Up by 3.24% on Mar 17: Drivers Behind the Movement - TradingKey
National Bank of Canada FI Buys 326,396 Shares of Lam Research Corporation $LRCX - MarketBeat
Larson Financial Group LLC Grows Stake in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Acquired by Gotham Asset Management LLC - MarketBeat
The Zacks Analyst Blog Highlights Philip Morris, Lam Research, Goldman Sachs, Palladyne and Eastern - Zacks Investment Research
Lam Research Corporation $LRCX Shares Bought by Focus Partners Wealth - MarketBeat
Lam Research Corporation (NASDAQ:LRCX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Top Analyst Reports for Philip Morris, Lam Research, and Goldman Sachs - Bitget
Top Research Reports for Philip Morris, Lam Research & Goldman Sachs - Yahoo Finance
What Does DRAM Memory Spending Trend Mean for Lam Research (LRCX) - Insider Monkey
LRCX SEC FilingsLam Research 10-K, 10-Q, 8-K Forms - Stock Titan
Lam Research Corp Stock (LRCX) Opened Up by 3.36% on Mar 16: Facts Behind the Movement - TradingKey
Lam Research (LCRX) Gained From Strong Demand Uptick - Insider Monkey
Jain Global LLC Boosts Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Alliancebernstein L.P. Sells 111,106 Shares of Lam Research Corporation $LRCX - MarketBeat
Is Lam Research Corporation (LRCX) A Good Stock To Buy Now? - Insider Monkey
Lam Research Corp Stock (ISIN: US5184391044) Faces Mixed Signals as Hedge Funds Trim Stakes Amid AI- - AD HOC NEWS
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lam Research Corp-Aktie (LRCX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bettinger Douglas R | Chief Financial Officer & EVP |
Mar 04 '26 |
Sale |
224.03 |
50,057 |
11,214,270 |
1,081,705 |
| Harter Ava | Chief Legal Officer |
Mar 04 '26 |
Sale |
222.66 |
1,500 |
333,990 |
53,205 |
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):